Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
AMAG Pharmaceuticals on Monday earned expanded FDA approval for its chronic kidney disease treatment Feraheme.
President Donald Trump pledged his support for the Right to Try Act during his State of the Union address last week. However, the bill, which would sidestep FDA regulations to give terminally ill patients access to experimental drugs, has seen…
Pfizer notified customers Jan. 31 it is having difficulty making certain prefilled syringes of opioid painkillers — marking the third time in six months the company has encountered manufacturing issues, reports STAT.
Amazon earned two patents for a wristband that could track warehouse workers' live hand movements, reports The New York Times.
Here are the four latest drugs or medical devices approved by the FDA since Jan. 12.
The FDA on Thursday approved Allergan's antibiotic, Avycaz, to treat two forms of pneumonia, reports Reuters.
Hospitals are experiencing a national shortage of sterile water for injection vials, according to the American Society of Health-System Pharmacists.
Marc Harrison, MD, president and CEO of Intermountain Healthcare, said he thinks a new generic drug company led by Intermountain Healthcare and three other health systems will eventually work with 1,000-plus hospitals, NEJM Catalyst reports.
Four health systems' venture to form a nonprofit generic drug company most captured readers' attention in January.
The FDA approved 16 personalized medicines in 2017 — a record-breaking number for the agency, according to a progress report published by the Personalized Medicine Coalition.